EdgarLookup

Allegion plc — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Allegion plc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
26.7%
Profit Margin
Net income ÷ revenue
12.3%
Return on Assets
Net income ÷ assets
2.39x
Debt-to-Equity
Total liabilities ÷ equity
+7.6%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $2.41B Feb 20, 2018
FY2017 Dec 31, 2016 $2.24B Feb 20, 2018
FY2017 Dec 31, 2015 $2.07B Feb 20, 2018

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.07B Feb 17, 2026
FY2025 Dec 31, 2024 $3.77B Feb 17, 2026
FY2025 Dec 31, 2023 $3.65B Feb 17, 2026
FY2024 Dec 31, 2022 $3.27B Feb 18, 2025
FY2023 Dec 31, 2021 $2.87B Feb 20, 2024
FY2022 Dec 31, 2020 $2.72B Feb 22, 2023
FY2021 Dec 31, 2019 $2.85B Feb 15, 2022
FY2020 Dec 31, 2018 $2.73B Feb 16, 2021
FY2019 Dec 31, 2017 $2.41B Feb 18, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $2.73B Feb 19, 2019
FY2018 Dec 31, 2017 $2.41B Feb 19, 2019
FY2018 Dec 31, 2016 $2.24B Feb 19, 2019
FY2017 Dec 31, 2015 $2.07B Feb 20, 2018
FY2016 Dec 31, 2014 $2.12B Feb 17, 2017
FY2015 Dec 31, 2013 $2.07B Feb 26, 2016
FY2014 Dec 31, 2012 $2.02B Feb 27, 2015

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $643.80M Feb 17, 2026
FY2025 Dec 31, 2024 $597.50M Feb 17, 2026
FY2025 Dec 31, 2023 $540.40M Feb 17, 2026
FY2024 Dec 31, 2022 $458.00M Feb 18, 2025
FY2023 Dec 31, 2021 $483.00M Feb 20, 2024
FY2022 Dec 31, 2020 $314.30M Feb 22, 2023
FY2021 Dec 31, 2019 $401.80M Feb 15, 2022
FY2020 Dec 31, 2018 $434.90M Feb 16, 2021
FY2019 Dec 31, 2017 $273.30M Feb 18, 2020
FY2018 Dec 31, 2016 $229.10M Feb 19, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $859.50M Feb 17, 2026
FY2025 Dec 31, 2024 $780.70M Feb 17, 2026
FY2025 Dec 31, 2023 $708.40M Feb 17, 2026
FY2024 Dec 31, 2022 $586.40M Feb 18, 2025
FY2023 Dec 31, 2021 $530.20M Feb 20, 2024
FY2022 Dec 31, 2020 $403.50M Feb 22, 2023
FY2021 Dec 31, 2019 $565.10M Feb 15, 2022
FY2020 Dec 31, 2018 $525.80M Feb 16, 2021
FY2019 Dec 31, 2017 $492.50M Feb 18, 2020
FY2018 Dec 31, 2016 $434.30M Feb 19, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.22B Feb 17, 2026
FY2025 Dec 31, 2024 $4.49B Feb 17, 2026
FY2025 Dec 31, 2023 $4.31B Feb 17, 2026
FY2024 Dec 31, 2022 $3.99B Feb 18, 2025
FY2023 Dec 31, 2021 $3.05B Feb 20, 2024
FY2022 Dec 31, 2020 $3.07B Feb 22, 2023
FY2021 Dec 31, 2019 $2.97B Feb 15, 2022
FY2020 Dec 31, 2018 $2.81B Feb 16, 2021
FY2019 Dec 31, 2017 $2.54B Feb 18, 2020
FY2018 Dec 31, 2016 $2.25B Feb 19, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.16B Feb 17, 2026
FY2025 Dec 31, 2024 $2.99B Feb 17, 2026
FY2024 Dec 31, 2023 $2.99B Feb 18, 2025
FY2023 Dec 31, 2022 $3.05B Feb 20, 2024
FY2022 Dec 31, 2021 $2.29B Feb 22, 2023
FY2021 Dec 31, 2020 $2.24B Feb 15, 2022
FY2020 Dec 31, 2019 $2.21B Feb 16, 2021
FY2019 Dec 31, 2018 $2.16B Feb 18, 2020
FY2018 Dec 31, 2017 $2.14B Feb 19, 2019
FY2017 Dec 31, 2016 $2.13B Feb 20, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $1.32B Feb 20, 2024
FY2023 Dec 31, 2022 $941.80M Feb 20, 2024
FY2022 Dec 31, 2021 $759.10M Feb 22, 2023
FY2021 Dec 31, 2020 $829.40M Feb 15, 2022
FY2020 Dec 31, 2019 $757.40M Feb 16, 2021
FY2019 Dec 31, 2018 $651.00M Feb 18, 2020
FY2018 Dec 31, 2017 $401.60M Feb 19, 2019
FY2017 Dec 31, 2016 $113.30M Feb 20, 2018
FY2016 Dec 31, 2015 $25.60M Feb 17, 2017
FY2015 Dec 31, 2014 ($4.80M) Feb 26, 2016

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 17, 2026
FY2025 Dec 31, 2024 6 Feb 17, 2026
FY2025 Dec 31, 2023 6 Feb 17, 2026
FY2024 Dec 31, 2022 5 Feb 18, 2025
FY2023 Dec 31, 2021 5 Feb 20, 2024
FY2022 Dec 31, 2020 3 Feb 22, 2023
FY2021 Dec 31, 2019 4 Feb 15, 2022
FY2020 Dec 31, 2018 4 Feb 16, 2021
FY2019 Dec 31, 2017 2 Feb 18, 2020
FY2018 Dec 31, 2016 2 Feb 19, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 17, 2026
FY2025 Dec 31, 2024 6 Feb 17, 2026
FY2025 Dec 31, 2023 6 Feb 17, 2026
FY2024 Dec 31, 2022 5 Feb 18, 2025
FY2023 Dec 31, 2021 5 Feb 20, 2024
FY2022 Dec 31, 2020 3 Feb 22, 2023
FY2021 Dec 31, 2019 4 Feb 15, 2022
FY2020 Dec 31, 2018 4 Feb 16, 2021
FY2019 Dec 31, 2017 2 Feb 18, 2020
FY2018 Dec 31, 2016 2 Feb 19, 2019

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $356.20M Feb 17, 2026
FY2025 Dec 31, 2024 $503.80M Feb 17, 2026
FY2024 Dec 31, 2023 $468.10M Feb 18, 2025
FY2023 Dec 31, 2022 $288.00M Feb 20, 2024
FY2022 Dec 31, 2021 $397.90M Feb 22, 2023
FY2021 Dec 31, 2020 $480.40M Feb 15, 2022
FY2020 Dec 31, 2019 $355.30M Feb 16, 2021
FY2019 Dec 31, 2018 $283.80M Feb 18, 2020
FY2018 Dec 31, 2017 $466.20M Feb 19, 2019
FY2017 Dec 31, 2016 $312.40M Feb 20, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.98B Feb 17, 2026
FY2025 Dec 31, 2024 $2.00B Feb 17, 2026
FY2024 Dec 31, 2023 $2.02B Feb 18, 2025
FY2023 Dec 31, 2022 $2.09B Feb 20, 2024
FY2022 Dec 31, 2021 $1.44B Feb 22, 2023